Name: Latest research reports of Ajanta Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Rocket

3326.3000 -19.00 (-0.57%)

NSE Jul 03, 2026 15:31 PM

New 52W High in past week

Volume: 83,885

Ajanta Pharma Ltd.

05 May 2026

3326.30

-0.57%

Strong beat on our 4Q estimates; robust outlook

Buy: Ajanta Pharma Ltd.

Motilal Oswal

Ajanta Pharma (AJP) delivered a better-than-expected 4QFY26, with a 10%/17%/21% beat on our revenue/EBITDA/PAT estimates.

Ajanta Pharma Ltd. is trading above all available SMAs